Perinatal infections due to group B streptococci.
Group B streptococci (GBS) emerged dramatically in the 1970s as the leading cause of neonatal infection and as an important cause of maternal uterine infection. We review the epidemiology, diagnosis, and therapy of GBS perinatal infection. In 1996, the first national consensus guidelines were released. Since then, there has been a 70% reduction in early-onset neonatal GBS infection, but no decrease in late-onset neonatal GBS disease. In 2002, new national guidelines were released recommending 1) solely a screen-based prevention strategy, 2) a new algorithm for patients with penicillin allergy, and 3) more specific practices in certain clinical scenarios. Yet many clinical issues remain, including implementation of new diagnostic techniques, management of preterm rupture of membranes, use of alternative antibiotic approaches, improvement of compliance, prevention of low birth weight infants, emergence of resistant organisms, and vaccine development.
Gibbs
Ronald S
RS
Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Denver, Colorado 80262, USA. ronald.gibbs@uchsc.edu
Schrag
Stephanie
S
Schuchat
Anne
A
D000465:Algorithms; D001428:Bacterial Vaccines; D002821:Chorioamnionitis / Q000453:epidemiology / Q000382:microbiology; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000382:microbiology; D019983:Guideline Adherence; D006801:Humans; D007231:Infant, Newborn; D008826:Microbial Sensitivity Tests; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology*; D013048:Specimen Handling; D013290:Streptococcal Infections / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D013292:Streptococcus agalactiae
D001428:Bacterial Vaccines